Previous session Next session

Emerging challenges in drug markets: monitoring, measurement & impacts

In programme

Friday, 25 October, 2024 - 10:50 to 12:20

View presentations

About

This panel focuses on emerging drug markets in Europe and Asia and examines new approaches for monitoring and addressing drug problems.

Presentations

Friday, 25 October

10:50

Short communication

An action plan for synthetic opioids - The Zurich approach

Dominique Schori

Short communication

Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia

Short communication

Development of an evidence-based classification framework for psychoactive substances in the illicit drug market

Michèle Boileau-Falardeau

Short communication

Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology

Gráinne Cousins

Short communication

Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS

Gregorio Planchuelo

Short communication

MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands

Lavinia Stegemann

Short communication

New research unit provides evidence to address national addictions policy challenges

Short communication

The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward

Previous session View the programme Next session

MENU

Lisbon Addictions 2024

My profile
Notifications
My favourites
Scan contacts
My contacts
Settings